Following Bellator 127, which was held at Pechanga Resort and Casino in California on October 3, it was revealed four Bellator fighters had failed their post-fight drug screenings under the California State Athletic Commission. All 22 fighters that took part in Bellator 127 were drug tested following their respective fights. The four fighters who tested positive can be found below:

Both Keith Berry , who earned a split decision over Joe Pacheco, and Nick Moghaddam , who dropped a decision to Ray Sloan, tested positive for elevated testosterone levels and marijuana.

, who earned a split decision over Joe Pacheco, and , who dropped a decision to Ray Sloan, tested positive for elevated testosterone levels and marijuana. Rob Emerson , a UFC veteran who dropped a decision to Rafael Silva, tested positive for Designer performance enhancer (Modafinil)

, a UFC veteran who dropped a decision to Rafael Silva, tested positive for Designer performance enhancer (Modafinil) Fernando Gonzalez, who walked away with a TKO victory over Karo Parisyan in the co-main event, tested positive for Marijuana

On Friday, Bellator President Scott Coker addressed the series of failed drug tests, revealing he and his company will fully support the the punishment handed down from the CSAC.

“I want to make very clear that under new management, Bellator will simply not stand for performance enhancing drugs inside our cage,” stated Bellator President Scott Coker in a press release. “We fully support the California State Athletic Commission in their process, and standby any disciplinary action handed out by Commissioner Andy Foster and the CSAC. Fans, media and our athletes need to have a clear understanding that drug use will simply not be tolerated by Bellator.”